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Summary.-Reticuloendothelial (RE) phagocytic and circulating plasma opsonic
activity was evaluated in rats transplanted with the Walker 256 carcinoma tumour
in an attempt to evaluate the role of opsonic protein in governing the functional state
of the macrophage system. Animals transplanted intramuscularly with 2 x 104
viable tumour cells manifested 2 peaks of RE stimulation at 6 and 14 days post-
transplantation with a subsequent decline in the phagocytic activity over the 14-30
day period. Increased phagocytic activity as determined by colloid clearance was
primarily a reflection of hepatic Kiupffer cell hyperphagocytosis while the decline in
phagocytic activity was related to a decrease in Kupifer cell function. The initial
peak of RE stimulation was associated with an elevation in the blood opsonin level
and no significant enlargement of the liver and spleen. In contrast, the second peak
of RE stimulation at 14 days was associated with both an elevation in opsonin levels
and an associated hepatic and splenic enlargement. The decline in phagocytic
activity over the 14-30 day interval was associated with a progressive decline in the
plasma opsonic activity, a return of the spleen to its normal size in relationship to
the body weight, and a persistent hepatomegaly. These findings suggest that the
alterations in macrophage function during tumour growth may be mediated in part
by changes in the opsonic or phagocytosis promoting capacity of plasma. Since
opsonic protein contributes to the discriminatory capacity of macrophages, it is
suggested that changes in the blood opsonin level may condition the anti-tumour
capacity of the macrophage system with respect to host defence against malignant
disease.
THE CRITICAL host defence role of
mononuclear macrophages or reticulo-
endothelial cells against cancer has been
emphasized repeatedly (Diller, Mankowski
and Fisher, 1963, DiLuzio et al., 1974a;
Old, Clarke and Benacerraf, 1959; Old
et al., 1960; Stern, 1960). Thus, data are
available to support the concept that
macrophages represent a primitive cellular
surveillance mechanism in response to
the presence oftumour cells. Stimulation
of the macrophage system before tumour
cell challenge will increase host resistance
to tumour growth (Diller et al., 1963;
Kampschmidt and Clabaugh, 1964; Old
et al., 1959; Stern, 1960) and experimental
depression of the macrophage system will
increase host susceptibility to tumour
challenge (Biozzi and Stiffel, 1965; Kamp-
schmidt and Clabaugh, 1964). Indeed,
as demonstrated by Stern (1960), there
exists an excellent correlation between
the level ofRES activity in various strains
of inbred mice which manifest clear
differences in the spontaneous incidence
of malignant disease.
A consistent observation made with
respect to the macrophage system and
neoplasia is the striking functional change
that develops by the host RES following
tumour cell challenge. This response is
typically an early activation ofthe macro-
phage system, followed by a decline in its
capacity at least with respect to phago-
cytosis (Old et al., 1960 1]961; Saba and
Antikatzides, 1972). Attempts to under-T. M. SABA AND T. G. ANTIKATZIDES
stand the basis for the RES alterations
have focused on the hepatic and splenic
RE cell hypertrophy and hyperplasia
coupled with hepatic and splenic enlarge-
ment (Kampschmidt and Pulliam, 1973;
Old et al., 1960; Stern, 1960) as the basis
for the increased RE activity as evaluated
by the clearance of intravenously injected
test colloids.
Recent findings from this laboratory
and others have accentuated the import-
ance of opsonin protein or so-called
humoral recognition factor (HRF) in the
control ofRE cell phagocytosis, especially
hepatic clearance activity (Allen, Sabaand
Molnar, 1973; DiLuzio et al., 1974b; Saba,
1975). Opsonic protein has been isolated
andis aheat-labile, largemolecularweight,
alpha-2-acid glycoprotein, unrelated to
complement and highly dependent on
heparin for expression of its phagocytosis
stimulating capacity (Allen et at., 1973;
Saba, 1970b, 1975). Determinations of
opsonin levels by bioassay have demon-
strated a decline following colloid induced
RE blockade, major surgery, burn injury
and traumatic shock (Saba, 1970a, b, 1972;
Saba and DiLuzio, 1969). Moreover,
Pisano et al. (1972) have demonstrated
opsonin or recognition factor depletion in
patients with advanced malignant disease
and a precipitate fraction of plasma
containing HRF or opsonin will inhibit
tumor growth in experimental animals
(DiLuzio et al., 1974b).
The fact that opsonin activity appears
to be essential for optimal phagocytosis
(Saba, 1970b, 1975; Saba and DiLuzio,
1965) coupled with the observations that
the rate of vascular clearance of test
colloids is modulated by the opsonin level
(Saba, 1972; Saba and DiLuzio, 1969)
suggest that the mechanism mediating
altered RE function during tumourgrowth
may be a functional alteration in the
plasma level ofthis protein and not exclu-
sively hypertrophy ofthe liver and spleen.
In the present investigation, the functional
phagocytic activity of the RES was
evaluated in rats during the growth ofthe
Walker 256 carcinoma tumour in relation-
ship to the plasma opsonin level in an
attempt to evaluate this concept. Add-
itionally, the relative hepatic and splenic
weight alterations during tumour growth
were determined in order to understand
the importance of such change in the
aetiology ofthe RES alterations observed.
MATERIALS AND METHODS
Animalts and transplantation technique.-
Male Holtzman rats weighing 60-70 g and
approximately 22-30 days of age were used
in all experiments as tumour recipients. They
were maintained on Tek-lab chow and tap
water ad tibitum before and following tumour
transplantation. Walker 256 donor tumour
bearing rats were originally obtained from
Microbiological Associates Inc. (Bethesda,
Md) and the tumour was subsequently main-
tained in our laboratory by serial transplant-
ation. The transplantation of the Walker
256 tumour was accomplished according to
the technique described by Snell (1953). In
this procedure, tumour donors were anaesthe-
tizedbylightetheranaesthesiaandthetumour
was excised under sterile conditions in a
transplantation box. The viable periphery
of the tumour mass was passed through a
No. 8, 177 um pore microsieve and cells were
collected in sterile saline and analysed for
viability by dye exclusion. Each recipient
rat received 2 x 104 viable cells intramuscu-
larly (recturfemoris) inaninjectionvolume of
0x2 ml. Controls were anaesthetized and
injected with 0x2 ml saline. Utilizing this
procedure there is a 98% "take'" rate in
terms of tumour growth (Saba and
Antikatzides, 1972) with a relatively uniform
growth rate.
Reticuloendothetial evaluation.-Reticulo-
endothelial function with reference to intra-
vascular phagocytic activity was evaluated
by a colloid clearance technique (Biozzi and
Stiffel, 1965; Saba, 1970b) with the use of a
radio-iodinated particulate lipid emulsion
referred to as the gelatinized 1311 "RE test
lipid emulsion" (Saba, 1972; Saba and
DiLuzio, 1969; Saba, Filkins and Diluzio,
1966). This technique has been used pre-
viously in the experimental evaluation of
phagocytic activity in animals and humans
andtheselectivelocalizationofthistestcolloid
in macrophages, especially in hepatic Kupffer
cells has been confirmed by electron micro-
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scopy (Saba, 1970b; Salky et al., 1964). The
test emulsion was prepared as an anhydrous
base by high-speed blendorization of 1311_
labelled triolein (Mallinckrodt Nuclear, St
Louis, Mo.), glycerol and alcohol-soluble
soya lecithin mixed in a ratio of 10: 10: 1
by weight respectively. Before in vivo use,
the anhydrous lipid base was supplemented
with a 0-30 gelatin containing sterile 500
dextrose and water solution previously
adjusted to pH 7-4 in order to yield an
emulsion with a 10% anhydrous base
concentration. The lipid emulsion was
incubated with oscillation at 37°C for 20
min before intravenous injection.
The rate of vascular clearance of the test
emulsion expressed as the "phagocytic index
(K)" was used as a measure of RE phagoeytic
activity (Biozzi and Stiffel, 1965; Old et al.,
1960; Saba, 1972). In this procedure, the
emulsion having a maximum specific activity
of 0 3 jtCi/mg was injected intravenously at a
dose of 50 mg/100 g body weight and serial
0 1 ml aliquots of whole blood were collected
from the cut tail at 2-min intervals and ana-
lysed for 1311 radioactivity. Post-injection
blood levels of the colloid expressed as the
percent ofthe injected dose circulating per ml
of blood (0%0ID/ml) were plotted semilogarith-
mically against time in min and the phago-
cytic index (K) for the vascular clearance of
the colloid was determined. Tissue
distribution oftheparticlesinrandomaliquots
of liver, lungs, and spleen was evaluated on
both a per g and total organ (TO) basis at
10 min post-injection, as previously described
(Saba, 1972; Saba and DiLuzio, 1969). All
tissue samples were washed in cold isotonic
saline to remove residual blood radioactivity
before isotopic analysis.
Since significant body and organ weight
alterations are apparent during tumour
growth the '"corrected phagoeytic index"
(os) previously used to measure phagoeytic
activity which accounts for deviations in
clearance capacity due to changes in organ or
body size (Biozzi and Stiffel, 1965; Biozzi
et al., 1958; Saba, 1970b) was calculated.
The corrected phagocytic index (a) was
calculated from the expression:
WLS <=3+,\/K x-W-
where K is the global phagocytic index, W
is thenetbody weight (grossbodywt - tumour
wt) and WLS is the combined weight of the
33
liver and spleen. The global phagocytic
index (K) was calculated from the expression:
K log C1-log C2
'T2-T1
where C1 and C2 represent the blood colloid
concentration attimesT1 andT2, respectively.
Control rats were evaluated at each time
interval in order to minimize experimental
error due to normal RES alterations during
the growth of the young recipient rats
(Saba, 1970b).
Plasma opsonin determinations.-The
opsonic activity ofnormal plasma and plasma
obtained from rats at various intervals
following tumour cell transplantation was
determined with a previously described
in vitro tissue slice bioassay (DiLuzio et al.,
1972; Pisano et al., 1972; Saba, 1972; Saba
et al., 1966).
Liver slices (200-300 mg) obtained from
normal animals were prepared with a Stadie-
Riggs tissue slicer and incubated in a medium
containing 1 ml of experimental plasma, 2 ml
of Krebs Ringer phosphate buffered to pH
7*4, 100 USP units of heparin (Upjohn,
Kalamazoo, Mich.), and 2 mg of the gelat-
inized 1311-RE test lipid emulsion (1% emul-
sion with 0.10% gelatin). All tissue slices
were incubated under a gas phase of95/0 02
and 500 CO2 with oscillation in a Dubnoff
metabolic shaker at 37°C for 30 min. Follow-
ing incubation, the liver slices were washed
in cold isotonic saline, weighed and analysed
for 1311 colloid uptake by Kupffer cells
(DiLuzio et al., 1972; Saba, 1970a, b; Saba
et al., 1966). The plasma opsonic activity
was evaluated in terms of its ability to
stimulate hepatic Kuffer cell phagocytosis
expressed as the percentage of the injected
dose (%ID) phagocytized per 100 mg of
tissue. This technique has been previously
used to evaluate opsonic of HRF activity in
animals (DiLuzio et al., 1972; Saba, 1970a, b;
Saba and DiLuzio, 1969) and humans (Pisano
et al., 1972) under a variety of experimental
conditions which includes patients with
malignant disease. This technique is based
on the fact that the opsonic protein in plasma
coats the particle (opsonization) before
phagocytosis and thus stimulates Kupffer
cell particle ingestion. The selective Kupffer
cell uptake of this particle in this tissue slice
preparation has been confirmed by i3topic
and microscopic techniques (S ;1-r Di-
Luzio, 1965, 1969).
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FiG. 1.-Growth curve of the Walker 256 carcinoma at the site of intramuscular transplantation.
Each point on the curve represents the average of 15 experimental animals. No growth was
detectable over the 0-4 day period. Data are expressedc on both a per g an(d % total body weight
basis.
Blood and tissue 1311 radioactivity was
determined with a Nuclear-Chicago auto-
gamma crystal scintillation system equipped
with a2-insodium iodidecrystal. Allsamples
were counted in duplicate with independent
standards in each experiment. The data
were statistically analysed by a PDP-12
digital computer with the Student's " t " test
placing the confidence limit at 9500.
RESULTS
Figure 1 shows the growth curve of
the Walker 256 tumour at the site of
transplantation over a period of 30 days,
which represents approximately the
maximum survival period. The tumour
was palpable about 6 days post-trans-
plantation and then manifested rapid
growth between the 6-18 day period.
Thereafter, the tumour weight, expressed
as 0% body weight, remained relatively
constant. Tumour bearing animals, as
compared with saline injected controls,
revealed very little impairment in body
weight gain over the first 24 days with a
slight decrease in weight gain over the
24-30 day period. Metastatic spread of
the tumour past the regional lymph node
was not apparent until the 8-10 day
interval. Thereafter, metastatic involve-
ment was clearly apparent in the lungs,
kidneys, liver, lymph nodes and adrenals
with the lung and distal lymph nodes
being major sites (Saba and Antikatzides,
1972). A complete lack of metastasis
was observed in the spleen and thymus in
126 rats evaluated.
RE function in control and tumour
bearing rats on the basis of the global
phagocytic index K is presented in Fig. 2.
A slight decrease in the K value was appa-
rentat 1 daypost-transplantation, followed
by 2 peaks of RE hyperphagocytosis at
6 and 14 days. Thus, in contrast to
control K values of 0-063±0 010 and
0 057±0*018 at 6 and 14 days respectively,
the tumour bearing rats had K values of
04190±0-029 (P<0-01) and 0-159±0*013
(P<0 01) at the 6 and 14 day period res-
pectively. Over the 14-30 day interval
there was a progressive declineintheglobal
phagocytic index compared with saline
injected age and weight matched control
rats.
In an attempt to determine the import-
ance of alterations in the relative liver
and spleen weight as a factor in the RES
stimulation, the corrected phagocytic
index (a) was then calculated (Biozzi
et al., 1958) after subtracting the primary
tumour weight from the gross bodyweight.
Presented in Fig. 3 is the corrected phago-
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FIG. 2.-Reticuloendothelial activity as the global phagocytic index (K) following tumour trans-
plantation. Data areexpressed as % control K with 6-7 controlsevaluated at each time interval in
a total of 70 control rats. Each point on the curve (0) represents an average of 7-18 rats injected
with 2 x 104 viable tumour cells with a total of 182 tumour bearing rats evaluated. Phagocytic
activity at 1, 6, and 14 days is significantly (P<0.01) different from controls.
cytic index (a) in the tumour bearing rats.
Even by this parameter, there was an
intense RE hyperphagocytosis over the
4-6 day period (P<0-05), followed by a
decline to control levels at 10 days and a
significant (P<0 05) secondpeak ofmacro-
phage activation at 14 days. Thus, at
6 days, control rats manifested an alpha
of 8-28±0-36 while tumour bearing rats
had an alpha of 11-86A0*73. At 14 days
alpha in the control group was 8-08±0-52
and 10-96±031 in the tumour bearing
rats. Thereafter, progressive decline in
RES activity was observed with a sig-
nificant REdepression (P<0 05) at 30days
(= 5-47I0-65).
To emphasize further the temporal
relationship of hepatomegaly and spleno-
megaly to the observed peaks of RE
stimulation, the organ weights are pre-
sented in Fig. 4. There was no sig-
nificant hepatomegaly or splenomegaly
during the intial peak of RE stimulation
over the 4-6 day period when expressed as
either the % net body weight with age
matched rats manifesting mean liver
weights of 4-21% net body weight or
spleen weights of 0.49% net body weight.
In contrast, significant (P<005) hyper-
trophy of the liver and spleen was appa-
rent by 14 days (liver = 6.22%; spleen
= 0.80%) with a disappearance of the
splenomegaly by 30 days but a clear
maintained existence ofthe hepatomegaly.
475T. M. SABA AND T. G. ANTIKATZIDES
0*
.. .
.410 -*
1-H -H-H
. OO - e o 0r 0 !,: Eq s b b > O . cC w
i4-~~~~~~~~~~~-
HH o-° f ~~~~~~~~~~
::3 ~ ~ ~ ~ c P- 0 o m 0c0z-H -HP-' -fl
$0 H co S~~~~~~~t P e
0~~~~~~
00 0~~~~~~0
6
0~~~~~
-e- ,0 e =, g e;
0
o i >~~~~~~t O: m oS.4
° 96' lM d' + O;E~~(D
co C , o *°?
o~~ ~~~~~o
2 >y X x41s-+41
0 o Bo
.Q.~ ~~~~ C m 1.° °
IV
C3 c 3=
*- CI.p ^ ,< *
C0
L oH~~~~~~~~~~~~~~c
476RES RESPONSE TO TUMOUR GROWTH
1 2 4 6 8 10
TIME POST- INTRAMUSCULAR TUMOUR CELL INJECTION (DAYS)
FIG. 3.-Reticuloendothelial activity as the corrected phagocytic index (cx) following tumour trans-
plantation. Data are expressed as % control (a) with 6-7 controls evaluated at each time interval
in a total of 70 rats. Similar to theexperimental rats in Fig. 2, each point (*)representsanaverage
of 7-18 tumour bearing rats with a total of 182 tumour rats evaluated. Phagocytic activity at
6, 14 and 30 days is significantly (P<0.05) different from controls.
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FIG. 4.-Relative liver and spleen weight alterations in the tumour bearing rats injected intramuscu-
larly with 2 x 104 viable tumour cells. Liver and spleen weights are expressed as °/0 gross body
weight (0%GBW) and % net body weight (%NBW). NBW was calculated by subtracting the
tumour weight from the GBW. The increased spleen size was significant (P<0-05) at the 14-day
interval, while the increased liver size was significant (P<0-05) over the 14-30 day period. Control
group consisted of 70 rats evaluated at various time intervals (6-7 per time), and tumour bearing
group consisted of 7-18 animals at each point with a total group of 182.
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The liver and spleen macrophage
phagocytic uptake of the test colloid is
presentedintheTableattimesofmaximum
RE alteration. Liver phagocytosis on
both a per g and total organ basis mani-
fested a slightly lower, but not significant,
decrease by 24 h post-transplantation.
Contfols manifested a progressive decrease
in co,lloid uptake per g liver as normally
associated with livergrowth. Incontrast,
the tumour bearing rats at 6 days and 14
days manifested increased (P<0 05)
hepatic Kupffer cell uptake. While not
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FIG. 5.-Plasma opsonic activity during
tumour growth compared with saline
injected controls. The control level repre-
sents the mean of all 89 determinations
done over the 30-day period. These were
pooled since a relatively constant level was
obtained over the entire experimental
period. All data areexpressed as the mean±
standard error ofthe mean withthenumber
of determinations in parentheses. Altera-
tions at 1, 6, 14, 24 and 30 daysweresignifi-
cant(P<0 05). Opsonicactivity ofplasma
is expressed in terms of its phagoeytosis
stimulatory capacityfor invitroKupffercell
golloid phagocytosis during a 30-min incu-
bation. Data expressed as % injected dose
2000 jug colloid dose (%ID) phagocytozed
per 100 mg tissue.
presented in the Table each period of
increased hepatic uptake was associated
withadeclineinthepulmonarylocalization
of the blood-borne test microparticles.
Splenic uptake manifested a variable
response with an unexpected intense
hyperphagocytosis by 24 h. As seen
from Fig. 3 and the Table, the alterations
in RE clearance activity were primarily
a reflection ofthe level of liver phagocytic
capacity.
Presented in Fig. 5 is the circulating
opsonic activity, assessed over the 30-day
period. Therewasanexcellentcorrelation
between the opsonic activity (Fig. 5) and
the observed state of the macrophage
system (Fig. 3). Specifically, at 6 and 14
days there was a 93% and 99% elevation
in the opsonin level respectively, in
association with these 2 periods of RE
stimulation. Moreover, the progressive
decline in phagocytosis over the 14-30
day period (Fig.2) was associated with a
significant (P<0-05) fall in the opsonin
activity,especiallyat 24 and 30 days when
the activity was 45% and 52% of control
levels which were 5-80I0-32 %ID/100 mg.
The apparent early, decline in opsonic
activity at 24 h was significant (P<0 05)
and may be related to the mild drop in
phagocytic level detected at this time
(Fig. 2, 3).
DISCUSSION
The reticuloendothelial system (RES)
is endowed with the physiological capacity
to rapidlyph*ocytoze foreign particulate
matter, denattred endogenous proteins,
tumour cells and effete autologous tissue
debris (Biozzi and Stiffel, 1965; Saba,
1970b, 1975). The major portion of the
RES consists of sessile macrophages
localized in the liver, spleen and bone
marrow which are in direct contact with
thecirculation. Inthisregard,thehepatic
Kuipffercellsfunctionallycompriseapproxi-
mately 80-90% of the total RE cell
phagocytic clearance activity.
Evaluation of RE function in humans
(Donovan, 1967; Salky et al., 1974) has
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shown that a marked alteration in phago-
cytic activity occurs in patients with
diseases of altered immunity, bacterial
infections and neoplasia. These findings
have accented the potential role of the
RES as an antibacterial and anti-tumour
defence mechanism. Indeed, RE stimu-
lation will afford protection against
experimentally induced infections (Biozzi
and Stiffel, 1965; Saba, 1970b), as well as
lead to a regression of tumour growth
(Biozzi et al., 1.958; Diller et al., 1963;
Old et al., 1959), while RE depression will
decrease host resistance to infection and
neoplastic disease (Biozzi et al., 1958;
Saba, 1970b).
Phagocytosis is intimately associated
with the macrophage " recognition " of
foreignness. Thus, macrophages can
discriminate between foreign matter (non-
self), altered endogenous tissue (altered-
self), and healthy indigenous tissue (self)
(Saba, 1970b). This capacity has been
suggested to be, in part, related to plasma
or serum factors (Allen et al., 1973; Pisano
et al., 1972; Saba, 1975) which interact
with the foreign or altered surface antd
stimulate phagocytosis. The delicate
humoral control of the RES is emphasized
by the fact that enhanced macrophage
activity can be correlated withi elevated
opsonic or recognition factor levels, while
depressed phagocytosis can be induced by
lowering opsonic activity (DiLuzio et al.,
1972; Saba, 1972; Saba and DiLuzio,
1969). This in vivo sensitivity to the
circulating opsonin level is especially
manifested by the Kupffer cells of the
liver (Saba, 1970b).
Macrophage defence mechanisms are
involved in the host's response to counter-
act the growth and spread of cancer
(Biozzi et al., 1958; DiLuzio et al., 1974a;
Old et al., 1960; Omori, 1964). Macro-
phage stimulation either before or during
the early stages of tumour growth will
inhibit tumour growth and spread; and
depression of the macrophage system will
accentuate tumour growth. For example,
Halpern, Biozzi and Stiffel (I963) observed
a clearprotective influence ofBCG- infection
against Sarcoma J in mice. They noted
that the apparent increased resistance
revealed by different strains of mice to
tumour growth was correlated with acti-
vation of the macrophage system, sug-
gestingthatmacrophage activation endows
the host with increased capacity to destroy
tumour cells. Additionally, activation
ofthe macrophage system has been shown
to be an important factor in the C. parvum
inhibition of tumour growth (Wolmark
and Fisher, 1974; Woodruff, Dunbar and
Ghaffar, 1973) especially since selective
inhibition ofT and B cell function (Castro,
1973; Woodruff et al., 1973) will not mini-
rmize the effectiveness of macrophage
activation byC.parvum ontumourgrowth.
These findings do not prove a direct
relationship between RES function and
tumour growth but do suggest that the
RES may exert a regulatory influence
over the course and pattern of tumour
development and growth. The findings
by Stern (1960) on RES activity in inbred
mice which manifest clear differences in
the spontaneous incidence of malignant
tumours further emphasizes the potential
role of the RES in neoplasia. Thus,
phagocytosis by hepatic Kupffer cells and
splenic macrophages was greatest in
animals manifesting the lowest incidence
of spontaneous tumours, while animals
exhibiting the greatest incidence of spon-
taneous tumours exhibited lower basal
levels ofRE activity. He postulated that
macrophage "failure or weakness" may
be a critical factor in tumour growth.
The present investigation has detion-
strated that sequential phasic alterations
of RES phagocytic capacity could be
closely correlated with the circulating
plasma level of recognition factor protein
or opsonic protein. This was most pro-
nounced at 6 and 14 days post-transplan-
tation when the intense increment of
plasma opsonin activity correlated with a
a state of Kupffer cell hyperphagocytosis.
Pisano et al. (1972) have recently demon-
strated that patients with advanced
carcinoma manifest very low opsonic or
recognition factor levels. These human
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studies correlate well with the present
animal findings, since the tumour bearing
rats by 24-30 days post-transplantation,
at a time of maximal tumour size and
extensive metastases, manifest severe
hypo-opsonaemia. Whether this is due to
a depletion of plasma opsonic protein by
the continual overload of the macrophage
cells in terms of tumour cell clearance
from the circulation, or possibly related to
the sequestration of opsonic protein from
blood to the site of tumour growth and
associated tissue necrosis can only be
speculated. The fact that intravenous
injection of tumour cells will lead to a
rapid decrease of the plasma opsonin
activity (DiLuzio et al., 1972; Saba et al.,
1974) as well as the observation that
purified 125J opsonic protein is sequestered
from the vascular compartment into a
site of tissue injury (Kaplan and Saba,
1974) supports either or both of these
mechanisms. However, one must con-
sider the possibility that the tumour may
exert a depressive effect on the RES by
inhibition of opsonic activity or impair-
ment of cellular phagocytic capacity.
Indeed, the recovery of opsonic protein
activity in patientswith metastatic disease
following surgical removal of the tumour
may indicate that its synthesis and/or
activity is suppressed during tumour
growth (Pisano, DiLuzio and Salky, 1970).
Old et al. (1960) demonstrated astriking
relationship between reticuloendothelial
function as reflected by carbon clearance
and the growth of various transplanted
and spontaneous tumours in mice. Thus,
with the transplanted sarcoma 180 tumour
in mice, there was minimal RES alteration
within 4 days, followed by RES stimu-
lation in association with splenic enlarge-
ment over the 7-12 day period. There-
after, progressive diminution in phago-
cytic activity was associated with pro-
gressive tumour growth and decreased
liver and spleen size. A similar response
exists with the transplantable adeno-
sarcoma 755 and associated with simul-
taneous enlargement of both the liver
and spleen (Old et al., 1960). Association
of the hepatic and splenic enlargement
with the enhanced RES clearance capacity
was further suggested by studies utilizing
the S180 ascites tumour model and the
Friend virus leukaemic model (Old et al.,
1960). In the present findings, the hepa-
tomegaly and splenomegaly were also
observed and indeed correlated with the
second peak of RES stimulation at 14
days. However, as presented in Fig. 2, 3
and 4, one cannot readily explain the
profound alterations in clearance capacity
throughout the experimental period on the
basis of organ size alterations alone since
no increment in relative liver and spleen
weight was observed at the 4-6 day
period during maximal RE stimulation.
Moreover, the RES was hypophagocytic
at the 30-day terminal stage, at a time of
normal spleen size and enlarged liver size.
In contrast, the parameter of opsonin or
HRF levels (Fig. 5) correlated to a high
degree throughout the experimental period
with the functional state of the reticulo-
endothelial system (Fig. 2. 3). Thus,
hyperopsonaemia was associated with
enhanced colloid clearance capacity
especially at 6 and 14 days, while hypo-
opsonaemia was associated with the pro-
gressive period of RE failure. The pre-
viously reported inverse relationship
between these 2 variables when adult rats
are the tumour recipients (Kampschmidt
and Pulliam, 1972) may reflect the known
variation in RES response to tumour
growth as influenced by age (Kamp-
schmidt and Clabaugh, 1964).
In contrast to the opsonin level alter-
ations in the tumour bearing rats, the
phagocytic capabilities of the Kiipffer
cell remain relatively constant if tested
in vitro in the presence of normal plasma
(Saba, 1975; Saba et al., 1974). Thus
hepatic Kupffer cells obtainedfromnormal
rats as well as from animals at 6, 1]4, and 30
days after transplantation manifest similar
phagocytic activity when incubated in
normal plasma. In contrast, macro-
phages derived from both normal animals
and from animals at various stages follow-
ing tumour cell transplantation exhibit
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hyperphagocytosis when incubated in
plasma from tumour bearing rats at 6 and
14 days and hypophagocytosis when
incubated in plasma derived from tumour
bearing ratsat30daysposttransplantation.
Thus, opsonic protein or so-called humoral
recognition factor (HRF) appears to exert
a regulatory role on the RES both in
normal and in tumour bearing animals.
A similar observation of humoral control
on the RES has been made repeatedly
especially with respect to RE alterations
following surgery, whole body trauma,
starvation and colloid-induced RE block-
ade (Saba, 1975, 1972; Saba and DiLuzio,
1969). Moreover, the passive adminis-
tration ofopsonicprotein (Allenetal., 1973)
or the opsonization of particles before
injection reverses the RE depression
after blockade, surgery and starvation
(Saba, 1970a; Saba and DiLuzio, 1969).
While the function of the RES correl-
ates with the opsonin levels, it is much
more difficult to explain the basis for the
variations in opsonic activity during
tutmour growth. The abrupt increase in
the opsonin level over the 4-6 day period
may represent a host-defence response in
which opsonic protein maintained in a
storage pool is released into the vascular
compartment (Saba, 1970b). The second
peak of elevated opsonin levels may
reflect increased synthesis of this factor in
response to excessive consumption. In
contrast, the progressive decline in the
opsonin level during the terminal phase
may reflect continual depletion of this
factor from the plasma compartment in
association with the vascular entrance of
tumour cells (Saba and Antikatzides,
1972; Saba et al., 1974).
The evidence supporting a role for the
macrophage system in tumour immunity
coupled with the intricate control that
this alpha-2-globulin opsonic protein has
on RE function provides the critical link
necessary for the potential utilization of
opsonic system manipulation as an
approach for tumour therapy. This
specific protein has been isolated and
partially characterized (Allen et al., 1973;
Saba, 1975), and its passive administration
may be ofdistinct benefit either separately
or in conjunction with other modalities of
cancer chemotherapy. The recent demon-
stration of inhibition of tumour growth
by opsonic protein or HRF in animals
(DiLuzio et al., 1974) coupled with the
regression of neoplastic lesions in humans
by a combination of HRF and glucan
administration supports this concept
(DiLuzio et al., 1974a). Indeed, these
findings suggest that the alpha-2-globulin
opsonic system (Saba, 1975) may be crit-
ical to the anti-tumour defence capacity
of the macrophage system.
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